Upcoming Allied Market Research
Cell Therapy Biomanufacturing Market

Cell Therapy Biomanufacturing Market

by Product Type (Consumable, Equipment, Software, and System), Cell Type (T-cell, Stem Cell, and Other Cell), Process (Cell Processing, Cell Preservation, Distribution, and Handling Process Monitoring & Quality Control), and End User (Biopharmaceutical & Biotechnology Companies and CROs, Research Institutes and Cell Banks): Global Opportunity Analysis and Industry Forecast, 2021-2030

Report Code: A13860
Pages: NA
Nov 2022 | 1047 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cell Therapy Biomanufacturing Market

Request Now !

Cell therapy bioprocessing is a subfield of bioprocess engineering that bridges cell therapy and biopharmaceutical manufacturing. Cell therapy is one of the fastest-growing areas of the life sciences. It entails delivering entire living cells to a patient to treat chronic and rare disorders. Despite being a niche domain of the biotechnology sector, cell and gene therapy have paved the investments by the contract development and manufacturing organizations (CDMO)/contract manufacturing organizations (CMO).
It involves the delivery of whole, living cells to a patient for the treatment of the disease. Typically, this category is divided into two main sections—autologous, meaning the cells are derived from the patient, and allogenic, meaning the cells are derived from another individual and show some match to the potential new host, similar to a blood transfusion. 

COVID-19 Impact analysis

  • The COVID-19 outbreak is predicted to have a minor or insignificant influence on the market for cell therapy technology. There is a greater need for an effective COVID-19 medicine or vaccination that could help to reduce the severity of the diseases with the growth of COVID-19 instances. Cell-based research is an important step in the production of vaccines, and help boost the growth of the market. The supply chain was disrupted during the early months of the COVID-19 outbreak, which caused the clinical studies to be delayed. This may have a negative impact on the market to some extent. Clinical trial delays have been revealed by biopharmaceutical companies, including significant players such as Pfizer and Eli Lilly.

Top Impacting Factors
The cell therapy biomanufacturing market is predicted to grow due to a greater focus on personalized medicine and increase in public-private partnerships for the development of cell treatments.
An increase in the frequency of cardiovascular illnesses, a rise in the demand for chimeric antigen receptor (CAR) T cell therapy, and the continued development of stem cell therapy methods are the factors propelling the cell therapy biomanufacturing market growth.
Customers and other stakeholders are collaborating with biomanufacturing companies to improve the clinical research and commercial manufacturing of these medicines. This in turn is expected to boost the growth of the cell therapy biomanufacturing market.
Manufacturers' bottlenecks during cell therapy commercialization, high costs involved with cell therapies, and absence of a qualified personnel to run complicated instruments limit the cell therapy biomanufacturing market growth.
Market Trends
New product launches to flourish the market

  • In November 2019, the Australian government released a 10-year roadmap for stem cell research in Australia—The Stem Cell Therapies Mission. The initiative is anticipated to provide USD 102 million (AU$150 million) under the Medical Research Future Fund (MRFF) to support stem cell research to deliver new therapies. 
  • In 2020, Lonza (Switzerland) collaborated with IsoPlexis (U.S.) to develop the next generation of precision cell therapy manufacturing.
  • In 2020, Biopharma business from General Electric Company’s Life Sciences division (U.S.) Danaher acquired the Biopharma business from General Electric Company’s Life Sciences division. The acquisition led to a new business named Cytiva, a standalone operating company within Danaher’s Life Sciences segment.
  • In 2019, Thermo Fisher Scientific invested ~USD 24 million in its Inchinnan (Scotland) site to expand its global bioproduction capabilities with additional large-volume liquid manufacturing capacity for cell culture media.

Key Benefits of the Report

  • This study presents the analytical depiction of the Cell Therapy Biomanufacturing along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the Cell Therapy Biomanufacturing market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the Cell Therapy Biomanufacturing market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed Cell Therapy Biomanufacturing market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Cell Therapy Biomanufacturing Report

  • Who are the leading market players active in the Cell Therapy Biomanufacturing market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
  • What is "Cell Therapy Biomanufacturing "?
  • What is "Cell Therapy Biomanufacturing " Market prediction in the future?
  • Who are the leading global players in the "Cell Therapy Biomanufacturing " Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "Cell Therapy Biomanufacturing " Market report?

Cell Therapy Biomanufacturing Market Report Highlights

Aspects Details
By Product Type
  • Consumables
  • Equipment
    • Cell Processing Equipment
    • Single-use Equipment
    • Other Equipment
  • Systems & Software
By Cell Type
  • T-cell
  • Stem Cell
  • Other Cell
By Process
  • Cell Processing
  • Cell Preservation, Distribution, and Handling
  • Process Monitoring and Quality Control
By End User
  • Biopharmaceutical & Biotechnology Companies and CROs
  • Research Institutes and Cell Banks
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany). MaxCyte (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Lonza Group (Switzerland, Sartorius AG (Germany), Terumo BCT (US), Fresenius Medical Care AG & Co. KGaA (Germany), Avantor, Inc. (US), Bio-Techne Corporation (US), Corning Incorporated (US), FUJIFILM Irvine Scientific (US), MaxCyte (US), Werum IT Solutions GmbH (Germany), RoosterBio Inc. (US), SIRION Biotech GmbH (Germany), CellGenix GmbH (Germany), L7 Informatics, Inc. (US), Miltenyi Biotec GmbH (Germany), STEMCELL Technologies (Canada), Hemasoft (US), MAK-SYSTEM (US), OrganaBio, LLC (US), IxCells Biotechnology (China), Wilson Wolf Corporation (US).

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now









Purchase Full Report of
Cell Therapy Biomanufacturing Market

Start reading.
This Report and over 18,833+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers